↓ Skip to main content

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

Overview of attention for article published in Lancet Infectious Diseases, October 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs
3 blogs
twitter
3912 X users
reddit
2 Redditors

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
22 Mendeley